Patients with cardiotoxic death or with secondary malignancies during follow-up
| Event . | CHOP-21, no. of patients . | I-CHOP, no. of patients . |
|---|---|---|
| Cardiotoxic death | 5 | 2 |
| Death from secondary malignancies | 2 (1 to lung cancer, 1 to gastric cancer) | 3 (1 to acute myeloid leukemia, 1 to ureter cancer, 1 to prostate cancer) |
| Alive with secondary malignancies | 4 (1 with breast cancer, 2 with skin cancer, 1 with cervical cancer) | 3 (1 with bladder cancer, 2 with skin cancer) |
| Event . | CHOP-21, no. of patients . | I-CHOP, no. of patients . |
|---|---|---|
| Cardiotoxic death | 5 | 2 |
| Death from secondary malignancies | 2 (1 to lung cancer, 1 to gastric cancer) | 3 (1 to acute myeloid leukemia, 1 to ureter cancer, 1 to prostate cancer) |
| Alive with secondary malignancies | 4 (1 with breast cancer, 2 with skin cancer, 1 with cervical cancer) | 3 (1 with bladder cancer, 2 with skin cancer) |